BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35100440)

  • 21. Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
    Johansson I; Tempel D; Dwarkasing JT; Rentroia-Pacheco B; Mattsson J; Ny L; Olofsson Bagge R
    Eur J Surg Oncol; 2022 Feb; 48(2):320-325. PubMed ID: 34794843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymph node biopsy followed by immediate and delayed ALND.
    Kuwajerwala NK; Feczko C; Dekhne N; Pettinga J; Lucia VC; Riutta J; Vicini F
    Am J Clin Oncol; 2013 Feb; 36(1):20-3. PubMed ID: 22157215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma].
    Litrowski N; Duval Modeste AB; Coquerel D; Courville P; Milliez PY; Joly P
    Ann Dermatol Venereol; 2013; 140(6-7):425-30. PubMed ID: 23773739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple lymphatic-venous anastomoses in reducing the risk of lymphedema in melanoma patients undergoing complete lymph node dissection. A retrospective case-control study.
    Nacchiero E; Maruccia M; Vestita M; Elia R; Marannino P; Giudice G
    J Plast Reconstr Aesthet Surg; 2019 Apr; 72(4):642-648. PubMed ID: 30799122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
    Killelea BK; Long JB; Dang W; Mougalian SS; Evans SB; Gross CP; Wang SY
    Ann Surg Oncol; 2018 Jun; 25(6):1521-1529. PubMed ID: 29516364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
    Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
    Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
    Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
    Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary web syndrome: an underappreciated complication of sentinel node biopsy in melanoma.
    Schuitevoerder D; White I; Fortino J; Vetto J
    Am J Surg; 2016 May; 211(5):846-9. PubMed ID: 26995594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.
    Miller CL; Specht MC; Skolny MN; Jammallo LS; Horick N; O'Toole J; Coopey SB; Hughes K; Gadd M; Smith BL; Taghian AG
    Breast Cancer Res Treat; 2012 Oct; 135(3):781-9. PubMed ID: 22941538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients.
    Persa OD; Knuever J; Rose A; Mauch C; Schlaak M
    Int J Dermatol; 2019 Feb; 58(2):185-189. PubMed ID: 30229888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study.
    Stassen RC; Mulder EEAP; Mooyaart AL; Francken AB; van der Hage J; Aarts MJB; van der Veldt AAM; Verhoef C; Grünhagen DJ
    Eur J Surg Oncol; 2023 Dec; 49(12):107249. PubMed ID: 37907016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients.
    Hettiaratchy SP; Kang N; O'Toole G; Allan R; Cook MG; Powell BW
    Br J Plast Surg; 2000 Oct; 53(7):559-62. PubMed ID: 11000070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
    Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
    de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
    Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.
    Picon AI; Coit DG; Shaha AR; Brady MS; Boyle JO; Singh BB; Wong RJ; Busam KJ; Shah JP; Kraus DH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9001-9009. PubMed ID: 16715435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer related lymphedema in patients with different loco-regional treatments.
    Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
    Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.
    Ul-Mulk J; Hölmich LR
    Dan Med J; 2012 Jun; 59(6):A4441. PubMed ID: 22677239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.